(Q39545067)

12 September 2017

title

The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study (English)

1 reference

chronic obstructive pulmonary disease

12 September 2017

0 references

0 references

1 reference

Esra Uzaslan

1

1 reference

12 September 2017

Bassam Mahboub

2

1 reference

12 September 2017

Majed Beji

3

1 reference

12 September 2017

Chakib Nejjari

4

1 reference

12 September 2017

Mohamed Awad Tageldin

5

1 reference

12 September 2017

Javaid Ahmed Khan

6

1 reference

12 September 2017

Salim Nafti

7

1 reference

12 September 2017

Nathir M Obeidat

8

1 reference

12 September 2017

Abdullah Sayiner

9

1 reference

12 September 2017

Siraj Wali

10

1 reference

12 September 2017

Nauman Rashid

11

1 reference

12 September 2017

Abdelkader El Hasnaoui

12

1 reference

12 September 2017

BREATHE Study Group

13

1 reference

12 September 2017

language of work or name

1 reference

1 December 2012

1 reference

12 September 2017

1 reference

12 September 2017

volume

106 Suppl 2

1 reference

12 September 2017

page(s)

S45-59

1 reference

What have we learned from large drug treatment trials in COPD?

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Symptom burden in chronic obstructive pulmonary disease and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

The burden of chronic obstructive pulmonary disease among employed adults

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Chronic obstructive pulmonary disease in the adult population within the Middle East and North Africa region: rationale and design of the BREATHE study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Smoking habits in the Middle East and North Africa: results of the BREATHE study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Development and first validation of the COPD Assessment Test.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Properties of the COPD assessment test in a cross-sectional European study.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP).

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in the Punjab Province of Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Prevalence of the main cardiovascular risk factors in Morocco: results of a National Survey, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Diabetes mellitus in Egypt: risk factors and prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

The global diabetes pandemic: the Tunisian experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Asthma insights and reality in Turkey (AIRET) study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Economic analysis of the Confronting COPD survey: an overview of results

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

The burden of COPD in the U.S.A.: results from the Confronting COPD survey

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

Attitudes and beliefs about COPD: data from the BREATHE study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2812%2970014-8

7 January 2021

10.1016/S0954-6111(12)70014-8

Identifiers

DOI

1 reference

12 September 2017

1 reference